TrialRetina (Philadelphia, Pa.)2012

Treatment of nonneovascular idiopathic macular telangiectasia type 2 with intravitreal ranibizumab: results of a phase II clinical trial.

Brian C Toy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.